Sleep Timing and Circadian Preferences in A Sample of Egyptian Patients With Hepatic Cirrhosis
NCT ID: NCT02710227
Last Updated: 2017-06-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
80 participants
OBSERVATIONAL
2018-09-30
2019-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Sleep Quality Among HCWs
NCT04549350
Evaluation of the Sleep Hygiene in the Lebanese Population During the COVID-19 Confinement Period.
NCT04372043
Sleep Disorders After TIPS
NCT03685994
Effects of Partial Sleep Deprivation on Cognitive Function of Anesthesiologists
NCT03784560
Influence of Sleep Regularity on Circadian Rhythms, Learning, Performance, and Mood
NCT02839070
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A disturbance of sleep is recognized as one of the early signs of hepatic encephalopathy. Reversal of sleep rhythm, drowziness and lethargy are classic signs of this disease. Sleep disturbance and excessive daytime somnolence are common in patients with cirrhosis. It was estimated that up to 70% of individuals with cirrhosis (regardless of etiology) experience sleep disturbances \[4\]. Difficulty falling asleep and a shift in sleep schedule toward the latter part of the night, which might be result in daytime sleepiness, are commonly reported findings in patients with hepatic cirrhosis without encephalopathy \[4\].
Individuals with hepatic cirrhosis (n=50) and healthy controls (n=30) were recruited. Sleep quality, sleep timing parameters and circadian preference were evaluated using the Pittsburgh Sleep Quality Index (PSQI), Sleep Timing Questionnaire (STQ) and The Composite Scale for Morningness (CSM) respectively
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
liver cirrhosis
Sleep quality, sleep timing parameters and circadian preference were evaluated using (PSQI), (STQ).
(PSQI), (STQ).
Sleep quality, sleep timing parameters and circadian preference were evaluated using (PSQI), (STQ).
control
Sleep quality, sleep timing parameters and circadian preference were evaluated using (PSQI), (STQ).
(PSQI), (STQ).
Sleep quality, sleep timing parameters and circadian preference were evaluated using (PSQI), (STQ).
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
(PSQI), (STQ).
Sleep quality, sleep timing parameters and circadian preference were evaluated using (PSQI), (STQ).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* controls
Exclusion Criteria
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sherief Abd-Elsalam
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sherief Abd-Elsalam
MD liver diseases
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mohamed yousef, MD
Role: PRINCIPAL_INVESTIGATOR
Hepatology and gastroenterology dept.-Tanta
Mohamed seleem, MD
Role: STUDY_DIRECTOR
Neuropsychiatry dept.- Tanta
Sherief Abd-Elsalam, MD
Role: STUDY_DIRECTOR
Hepatology and gastroenterology dept.-Tanta
Mohamed Elhendawy, MD
Role: STUDY_CHAIR
Hepatology and gastroenterology dept.-Tanta
Sabry Abou saif, MD
Role: STUDY_CHAIR
Hepatology and gastroenterology dept.-Tanta
Abdelrahman Kobtan, MD
Role: STUDY_CHAIR
Hepatology and gastroenterology dept.-Tanta
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tanta university - faculty of medicine
Tanta, Elgharbia, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Sleep Patterns in cirrhotics
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.